ASP Isotopes Inc. (JSE:ISO)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc | Market Cap | 10.10B -32.8% |
| Revenue (ttm) | 505.90M +573.4% |
| Net Income | -2.17B |
| EPS | -19.99 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 40,781 |
| Open | 6,309.00 |
| Previous Close | 6,369.00 |
| Day's Range | 6,220.00 - 6,536.00 |
| 52-Week Range | 5,900.00 - 150,000.00 |
| Beta | 3.62 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |
About ASP Isotopes
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages... [Read more]
Financial Performance
In 2025, ASP Isotopes's revenue was $23.85 million, an increase of 475.51% compared to the previous year's $4.14 million. Losses were -$175.09 million, 398.6% more than in 2024.
Financial numbers in USD Financial StatementsNews
ASP Isotopes Announces Quantum Leap Energy is Evaluating Metal Conversion Opportunities in Namibia
DALLAS, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“we,” "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedic...
ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring...
ASP Isotopes Quarterly report: Q2 2026
ASP Isotopes has published its Q2 2026 quarterly earnings report on August 14, 2026.
ASP Isotopes Transcript: Canaccord Genuity's 46th Annual Growth Conference
The company is expanding its vertically integrated isotope and helium production, targeting electronics, nuclear medicine, and energy markets. Major projects include U.S. radiopharmacy acquisitions, a large-scale helium facility, and new nuclear fuel technologies, with significant revenue and EBITDA growth expected by 2031.
ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa
Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has entered into an additional take-or-pay contract to supply liquified natural gas (LNG) to a domestic food processor, ...
ASP Isotopes to Participate in Citi's 2026 Natural Resources Conference
DALLAS, Aug. 05, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the pro...
ASP Isotopes Issues Letter to Shareholders
DALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes”, “ASPI” or the “Company”), an advanced materials company focused on developing technologies and processes for...
ASP Isotopes to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026
DALLAS, July 30, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the pro...
ASP Isotopes to Hold Capital Markets Day on September 8
DALLAS, July 28, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the pro...
ASP Isotopes Transcript: Investor update
Noble Africa is advancing a world-class helium project in South Africa, with phase I plant completion and first shipments expected by September. The company benefits from unique geology, strong funding, and long-term contracts amid global supply shortages. Phase II will significantly expand capacity by 2031, positioning the firm as a leading pure-play helium producer.
ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technology
DALLAS, July 21, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“we,” "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedic...
Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company
DALLAS & ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or “ASPI”), an advanced materials company focused on developing technologies and processes...
ASP Isotopes Announces Agreements to Exchange Certain QLE Convertible Notes for ASPI Common Stock
Exchange reduces QLE's outstanding convertible notes by approximately 50% as QLE continues to pursue a public listing as a separate company Exchange reduces QLE's outstanding convertible notes by appr...
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
DALLAS & ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes," “ASPI” or the "Company"), an advanced materials company focused on developing technologie...
ASP Isotopes Slides: Corporate presentation
ASP Isotopes has posted slides in relation to its latest quarterly earnings report, which was published on June 24, 2026.
ASP Isotopes Implements Engineering Enhancements to Silicon-28 Enrichment Facility; Successfully Restarts First 18 Stages of Silicon-28 Enrichment Facility; Commercial Shipments of Enriched Silicon-28 Expected to Commence in Q3 2026
ASP Isotopes has previously announced that it has signed three commercial contracts for the supply of enriched Silicon-28 to U.S.-based customers, and expects to make initial commercial shipments of e...
ASP Isotopes Quarterly report: Q1 2026
ASP Isotopes has published its Q1 2026 quarterly earnings report on May 20, 2026.
ASP Isotopes Slides: Corporate presentation
ASP Isotopes has posted slides in relation to its latest quarterly earnings report, which was published on May 12, 2026.
Quantum Leap Energy Enters into Memorandum of Understanding with European Nuclear Technology Company for Advanced Nuclear Fuel Supply Collaboration
MOU establishes framework for collaboration with the goal to supply HALEU to European advanced reactor developer, beginning 2028 MOU establishes framework for collaboration with the goal to supply HAL...
Quantum Leap Energy Appoints Dr. Peter Fiske to Strategic Advisory Board
Technology Commercialization Leader Expected to Enhance QLE's Government Partnerships and Advanced Materials Strategy Technology Commercialization Leader Expected to Enhance QLE's Government Partnersh...
ASP Isotopes Earnings Call Transcript: Q4 2025
Transitioning to commercial operations, revenue surged 480% in 2025, with major product launches and U.S. expansion planned for 2026. EBITDA is targeted to exceed $300 million by 2031, driven by strong demand in isotopes, helium, and electronic gases.
ASP Isotopes Earnings release: Q4 2025
ASP Isotopes released its Q4 2025 earnings on April 13, 2026, summarizing the period's financial results.
ASP Isotopes Annual report: Q4 2025
ASP Isotopes has published its Q4 2025 annual report on April 13, 2026.
ASP Isotopes Slides: Q4 2025
ASP Isotopes has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on April 13, 2026.
ASP Isotopes Inc. Provides Business Update
First Commercial Shipments Expected Across Multiple Isotopes in 2026 Expect to Obtain Helium Phase 1 Nameplate Capacity in Q3 2026 EBITDA Target of Greater Than $300 Million in 2031 Cash, Cash Equival...